ReviewDrug delivery and translational research2026
Electron paramagnetic resonance (EPR) meets drug delivery and biomaterials: a magnetic love story.
Review in Drug delivery and translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Continuous-Wave Electron Paramagnetic Resonance Spectroscopy in Pharmaceutical Research: Current Applications and Emerging Opportunities.Pharmaceuticals (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
This narrative review underscores the powerful role of Electron Paramagnetic Resonance (EPR), also known as Electron Spin Resonance (ESR), in characterizing drug delivery systems (DDSs). Using drugs or probes tagged with spin labels, EPR provides detailed insights into structural and dynamic properties, as well as the molecular microenvironment (including micro-viscosity, micro-polarity, and micro-pH) and enables real-time monitoring of drug release and degradation processes both in vitro and in vivo. In nanomedicine research, EPR can also serve as a quantitative tool to track the fate of DDSs doped with iron oxide particles that are used in theranostics. Beyond DDS characterization, EPR has contributed substantially to elucidating radical mechanisms within material matrices, notably in bone cements and dental resins used for restorative applications. Moreover, incorporating paramagnetic compounds into DDSs or biomaterials has broadened the scope of EPR applications, enabling precise measurements of oxygen and nitric oxide levels in complex biological environments. The incorporation of oxygen sensors into biocompatible matrices has also enabled the development of implantable resonators for measuring oxygen at substantial tissue depths. Incorporating oxygen sensors into cell therapy implantable devices or grafted tissues can serve as an indicator of both oxygenation and vascularization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.